In addition, mRNA expression levels of S100A8 and S100A9 were analyzed in liver tissue samples from 32 HBV-ACLF patients, 19 hepatic hemangioma patients (used as healthy controls), and 10 CHB patients. Here, S100A9 is linked to liver hemangioma.